Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-25-060104
Filing Date
2025-04-29
Accepted
2025-04-29 16:07:46
Documents
19
Period of Report
2025-04-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A acet-20250429.htm   iXBRL DEF 14A 1468166
2 GRAPHIC img106651080_0.jpg GRAPHIC 11570
3 GRAPHIC img106651080_1.jpg GRAPHIC 11570
4 GRAPHIC img106651080_2.jpg GRAPHIC 299210
5 GRAPHIC img106651080_3.jpg GRAPHIC 326308
6 GRAPHIC img106651080_4.jpg GRAPHIC 404005
7 GRAPHIC img106651080_5.jpg GRAPHIC 335285
  Complete submission text file 0000950170-25-060104.txt   6303033

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT acet-20250429.xsd EX-101.SCH 32701
21 EXTRACTED XBRL INSTANCE DOCUMENT acet-20250429_htm.xml XML 670184
Mailing Address 131 DARTMOUTH STREET 3RD FLOOR BOSTON MA 02116
Business Address 131 DARTMOUTH STREET 3RD FLOOR BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

EIN.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38359 | Film No.: 25887415
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)